Logo

Roche's Ab Cocktail (Casirivimab and Imdevimab) Receives EUA to Treat COVID-19 in India

Share this
Roche's Ab Cocktail (Casirivimab and Imdevimab) Receives EUA to Treat COVID-19 in India

Roche's Ab Cocktail (Casirivimab and Imdevimab) Receives EUA to Treat COVID-19 in India

Shots:

  • The CDSCO has granted a EUA for Roche’s casirivimab and imdevimab to treat COVID-19 in India. The approval of the Ab cocktail was based on the data that has been filed for the EUA in the US and the CHMP’s opinion in the EU
  • Roche will import the globally manufactured product batches to India and is collaborated with Cipla for pan-India distribution. At a global level- Roche and Regeneron are collaborating to jointly address the increasing demand
  • Earlier- Roche has reported the global P-III trial of Abs vs PBO in 4-567 high-risk non-hospitalized COVID-19 patients and showed a 70% reduction in the risk of hospitalization or death and also shortened the duration of symptoms @4days

  Ref: Cipla | Image: Roche 

Click here to­ read the full press release 

Tuba

Tuba was Senior Editor at PharmaShots. She was curious, creative, and passionate about recent updates and innovations in the life sciences industry. She covered Biopharma, MedTech, and Digital health segments. Tuba also had an experience in digital and social media marketing and ran the campaigns independently. She can be contacted at connect@pharmashots.com.

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions